🇺🇸 FDA
Patent

US 7732445

Myosin light chain kinase inhibitor compounds, compostions and related methods of use

granted A61KA61K31/497A61K31/501

Quick answer

US patent 7732445 (Myosin light chain kinase inhibitor compounds, compostions and related methods of use) held by Northwestern University expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/497, A61K31/501, A61P, A61P1/16